Erratum: Functional changes in the language network in response to increased amyloid β deposition in cognitively intact older adults (Cerebral Cortex (2016) 26 (358-373) DOI: 10.1093/cercor/bhu286);Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults

Cerebral Cortex

Volumn 26, Issue 1, 2016, Pages 358-373

  Adamczuk, Katarzyna ^a   De Weer, An Sofie ^a   Nelissen, Natalie ^a,b   Dupont, Patrick ^a   Sunaert, Stefan ^a,c   Bettens, Karolien ^d,e   Sleegers, Kristel ^d,e   Van Broeckhoven, Christine ^d,e   Van Laere, Koen ^a,c   Vandenberghe, Rik ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

18F flutemetamol, semantic; Alzheimer; amyloid PET; fMRI

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BRAIN DERIVED NEUROTROPHIC FACTOR; FLUTEMETAMOL F 18; AMYLOID;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; ASSOCIATIVE MEMORY; BRAIN; BRAIN SIZE; COGNITION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENOTYPE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; INFERIOR FRONTAL GYRUS; LANGUAGE; MALE; MIDDLE TEMPORAL GYRUS; NORMAL HUMAN; OCCIPITAL GYRUS; PRIORITY JOURNAL; REACTION TIME; SEMANTIC MEMORY; VISION; ALZHEIMER DISEASE; METABOLISM; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SEMANTICS;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; BRAIN; HUMANS; LANGUAGE; MAGNETIC RESONANCE IMAGING; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; SEMANTICS;

EID: 84958807467     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhw117     Document Type: Erratum

References (94)

1. Adamczuk K, De Weer AS, Nelissen N, Chen K, Sleegers K, Bettens K, Van Broeckhoven C, Vandenbulcke M, Thiyyagura P, Dupont P, et al. 2013. Polymorphism of brain derived neurotrophic factor influences amyloid load in cognitively intact apolipoprotein E ?4 carriers. Neuroimage Clin. 2: 512-520.
2. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, et al. 2008. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 65: 1509-1517.
3. Apostolova LG, Lu P, Rogers S, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. 2008. 3D mapping of language networks in clinical and pre-clinical Alzheimer's disease. Brain Lang. 104: 33-41.
4. Arendt T, Schindler C, Brückner MK, Eschrich K, Bigl V, Zedlick D, Marcova L. 1997. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci. 17: 516-529.
5. Bastiaanse R, Bosje M, Visch-Brink E. 1995. Psycholinguïstische testbatterij voor de taalverwerking van Afasiepatiënten (PALPA). Hove (UK): Lawrence Erlbaum Associates.
6. Bayles KA, Tomoeda CK. 1983. Confrontation naming impairment in dementia. Brain Lang. 19: 98-114.
7. Becker JT, Mintun MA, Aleva K, Wiseman MB, Nichols T, DeKosky ST. 1996. Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology. 46: 692-700.
8. Binder JR, Frost JA, Hammeke TA, Bellgowan PS, Springer JA, Kaufman JN, Possing ET. 2000. Human temporal lobe activation by speech and nonspeech sounds. Cereb Cortex. 10: 512-528.
9. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, et al. 2005. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 25: 7709-7717.
10. Cabeza R. 2002. Hemispheric asymmetry reduction in older adults: The HAROLD model. Psychol Aging. 17: 85-100.
11. Cabeza R, Nyberg L, Park DC. 2005. Cognitive Neuroscience of Aging. New York (NY): Oxford University Press.
12. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S, Flowers L, Wood F, Maldjian JA. 2007. Biological parametric mapping: A statistical toolbox for multimodality brain image analysis. Neuroimage. 34: 137-143.
13. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, et al. 2006. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. J Neurosci. 26: 10222-10231.
14. Chertkow H, Bub D. 1990. Semantic memory loss in dementia of Alzheimer's type. What do various measures measure? Brain. 113: 397-417.
15. Chételat G, La Joie R, Villain N, Perrotin A, de La Sayette V, Eustache F, Vandenberghe R. 2013. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage Clin. 2: 356-365.
16. Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC. 2012. Accelerated cortical atrophy in cognitively normal elderly with high ?-amyloid deposition. Neurology. 78: 477-484.
17. Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, et al. 2012. Cerebral PET with florobetapir compared with neuropathology at autopsy for detection of neuritic amyloid-? plaques: A prospective cohort study. Lancet Neurol. 11: 669-678.
18. Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, et al. 2011. Use of florobetapir-PET for imaging beta-amyloid pathology. JAMA. 305: 275-283.
19. Clark LJ, Gatz M, Zheng L, Chen YL, McCleary C, Mack WJ. 2009. Longitudinal verbal fluency in normal aging, preclinical, and prevalent Alzheimer's disease. Am J Alzheimers Dis Other Demen. 24: 461-468.
20. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L. 1988. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 38: 1682-1687.
21. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. 1999. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 58: 376-388.
22. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, et al. 2005. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 65: 404-411.
23. Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, et al. 2012. Amyloid-? assessed by florobetapir F 18 PET and 18-month cognitive decline: A multicenter study. Neurology. 79: 1636-1644.
24. Driscoll I, Resnick SM, Troncoso JC, An Y, O'Brien R, Zonderman AB. 2006. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol. 60: 688-695.
25. Erickson KI, VossMW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, et al. 2011. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. 108: 3017-3022.
26. Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW. 2005. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol. 62: 1881-1888.
27. Freundlieb N, Philipp S, Schneider SA, Brüggemann N, Klein C, Gerloff C, Hummel FC. 2012. No association of the BDNF val66-met polymorphism with implicit associative vocabulary and motor learning. PLoS One. 7: e48327.
28. Golby A, Silverberg G, Race E, Gabrieli S, O'Shea J, Knierim K, Stebbins G, Gabrieli J. 2005. Memory encoding in Alzheimer's disease: An fMRI study of explicit and implicit memory. Brain. 128: 773-787.
29. Gorski JA, Zeiler SR, Tamowski S, Jones KR. 2003. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci. 23: 6856-6865.
30. Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI. 2001. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain. 124: 739-756.
31. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE. 2003. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci. 23: 986-993.
32. Grossman M, Koenig P, DeVita C, Glosser G, Moore P, Gee J, Detre J, Alsop D. 2003. Neural basis for verb processing in Alzheimer's disease: An fMRI study. Neuropsychology. 17: 658-674.
33. Grossman M, Koenig P, Glosser G, DeVita C, Moore P, Rhee J, Detre J, Alsop D, Gee J. 2003. Neural basis for semantic memory difficulty in Alzheimer's disease: An fMRI study. Brain. 126: 292-311.
34. Hatashita S, Yamasaki H, Suzuki Y, Tanaka K, Wakebe D, Hayakawa H. 2014. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease. Eur J Nucl Med Mol Imaging. 41: 290-300.
35. Herholz K, Ebmeier K. 2011. Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol. 10: 667-670.
36. Howard D, Patterson KE. 1992. The Pyramids and Palm Trees Test: A Test of Semantic Access from Words and Pictures. Bury St. Edmunds (UK): Thames Valley Test Company.
37. Huff FJ, Corkin S, Growdon JH. 1986. Semantic impairment and anomia in Alzheimer's disease. Brain Lang. 28: 235-249.
38. Hyman BT, Kromer LJ, Van Hoesen GW. 1987. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease. Ann Neurol. 21: 259-267.
39. Johnson SC, Schmitz TW, Moritz CH, Meyerand ME, Rowley HA, Alexander AL, Hansen KW, Gleason CE, Carlsson CM, Ries ML, et al. 2006. Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiol Aging. 27: 1604-1612.
40. Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA. 2006. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci. 26: 6069-6076.
41. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A. 1988. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 23: 138-144.
42. Kebir O, Mouaffak F, Chayet M, Leroy S, Tordjman S, Amado I, Krebs MO. 2009. Semantic but not phonological verbal fluency associated with BDNF Val66Met polymorphism in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 150B: 441-442.
43. Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, Vandenberghe R, Van Laere K. 2009. Whole-body biodistribution and radiation dosimetry of 18F-GE067: A radioligand for in vivo brain amyloid imaging. J Nucl Med. 50: 818-822.
44. Laiacona M, Capitani E. 2001. Acase of prevailing deficit of nonliving categories or a case of prevailing sparing of living categories? Cogn Neuropsychol. 18: 39-70.
45. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ. 1996. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology. 46: 413-419.
46. Li N, Bartlett CW. 2012. Defining the genetic architecture of human developmental language impairment. Life Sci. 90: 469-475.
47. Li Y, LuikartBW, Birnbaum S, Chen J, Kwon CH, Kernie SG, Bassel-Duby R, Parada LF. 2008. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron. 59: 399-412.
48. Machulda MM, Ward HA, Borowski B, Gunter JL, Cha RH, O'Brien PC, Petersen RC, Boeve BF, Knopman D, Tang-Wai DF, et al. 2003. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology. 61: 500-506.
49. Mendez MF. 2012. Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD. Arch Med Res. 43: 677-685.
50. Mesulam MM. 1999. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron. 24: 521-529.
51. Mez J, Cosentino S, Brickman AM, Huey ED, Mayeux R. 2013. Different demographic, genetic, and longitudinal traits in language versus memory Alzheimer's subgroups. J Alzheimers Dis. 37: 137-146.
52. Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, Hock C, Streffer J, Henke K. 2006. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain. 129: 2908-2922.
53. Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA. 2009. Pittsburgh compound B imaging and prediction of progression fromcognitive normality to symptomatic Alzheimer disease. Arch Neurol. 66: 1469-1475.
54. Müller-Gärtner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, Davatzikos C, Frost JJ. 1992. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 12: 571-583.
55. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264: 850-852.
56. Nelissen N, Dupont P, Vandenbulcke M, Tousseyn T, Peeters R, Vandenberghe R. 2011. Right hemisphere recruitment during language processing in frontotemporal lobar degeneration and Alzheimer's disease. J Mol Neurosci. 45: 637-647.
57. Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters R, Dupont P, Van Laere K, Bormans G, Vandenberghe R. 2007. Abeta amyloid deposition in the language system and how the brain responds. Brain. 130: 2055-2069.
58. Nelissen N, Van Laere K, Thurfjell L, Owenius R, VandenbulckeM, Koole M, Bormans G, Brooks DJ, Vandenberghe R. 2009. Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med. 50: 1251-1259.
59. Okuno H, Tokuyama W, Li YX, Hashimoto T, Miyashita Y. 1999. Quantitative evaluation of neurotrophin and trk mRNA expression in visual and limbic areas along the occipitotemporo-hippocampal pathway in adult macaque monkeys. J Comp Neurol. 408: 378-398.
60. Osada T, Adachi Y, Kimura HM, Miyashita Y. 2008. Towards understanding of the cortical network underlying associative memory. Philos Trans R Soc Lond B Biol Sci. 363: 2187-2199.
61. Pallier C. 2002. Computing discriminability and bias with the R software. URL Available from: URL http: //www. pallier. org/ ressources/aprime/aprime. pdf.
62. Price CJ, Mechelli A. 2005. Reading and reading disturbance. Curr Opin Neurobiol. 15: 231-238.
63. Price JL, Morris JC. 1999. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol. 45: 358-368.
64. Rasmusson DX, Dal Forno G, Brandt J, Warren AC, Troncoso J, Lyketsos C. 1996. Apo-E genotype and verbal deficits in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 8: 335-337.
65. Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, et al. 2012. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol. 11: 1048-1056.
66. Resnick SM, Sojkova J, Zhou Y, An Y, Ye W, Holt DP, Dannals RF, Mathis CA, Klunk WE, Ferrucci L, et al. 2010. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology. 74: 807-815.
67. Ricci PT, Zelkowicz BJ, Nebes RD, Meltzer CC, Mintun MA, Becker JT. 1999. Functional neuroanatomy of semantic memory: recognition of semantic associations. Neuroimage. 9: 88-96.
68. Saykin AJ, Flashman LA, Frutiger SA, Johnson SC, Mamourian AC, Moritz CH, O'Jile JR, Riordan HJ, Santulli RB, Smith CA, et al. 1999. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation. J Int Neuropsychol Soc. 5: 377-392.
69. Seidenberg M, Guidotti L, Nielson KA, Woodard JL, Durgerian S, Antuono P, Zhang Q, Rao SM. 2009. Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology. 73: 612-620.
70. Simmons TR, Flax JF, Azaro MA, Hayter JE, Justice LM, Petrill SA, Bassett AS, Tallal P, Brzustowicz LM, Bartlett CW. 2010. Increasing genotype-phenotype model determinism: Application to bivariate reading/language traits and epistatic interactions in language-impaired families. Hum Hered. 70: 232-244.
71. Small SA, Perera GM, DeLaPaz R, Mayeux R, Stern Y. 1999. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol. 45: 466-472.
72. Snodgrass JG, Vanderwart M. 1980. A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. J Exp Psychol HumLearn. 6: 174-215.
73. Sperling R. 2007. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann N Y Acad Sci. 1097: 146-155.
74. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, et al. 2011. Toward defining the preclinical stages of Alzheimer's disease: recommendations fromthe National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7: 280-292.
75. Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS. 2003. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry. 74: 44-50.
76. Sugarman MA, Woodard JL, Nielson KA, Seidenberg M, Smith JC, Durgerian S, Rao SM. 2012. Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk. Biochim Biophys Acta. 1822: 442-456.
77. Thurfjell L, Lilja J, Lundqvist R, Buckley C, Smith A, Vandenberghe R, Sherwin P. 2014. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. J Nucl Med. 55: 1623-1628.
78. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH. 1996. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 17: 365-371.
79. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 15: 273-289.
80. Vandenberghe R, Adamczuk K, Dupont P, Van Laere K, Chételat G. 2013. Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin. 2: 497-511.
81. Vandenberghe R, Adamczuk K, Van Laere K. 2013. The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease. Curr Opin Neurol. 26: 646-655.
82. Vandenberghe R, Nelissen N, Salmon E, Ivanoiu A, Hasselbalch S, Andersen A, Korner A, Minthon L, Brooks DJ, Van Laere K, et al. 2013. Binary classification of 18F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI. Neuroimage. 64: 517-525.
83. Vandenberghe R, Price C, Wise R, Josephs O, Frackowiak RS. 1996. Functional anatomy of a common semantic system for words and pictures. Nature. 383: 254-256.
84. Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, et al. 2010. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Ann Neurol. 68: 319-329.
85. Vandenberghe R, Wang Y, Nelissen N, Vandenbulcke M, Dhollander T, Sunaert S, Dupont P. 2013. The associativesemantic network for words and pictures: effective connectivity and graph analysis. Brain Lang. 127: 264-272.
86. Vandenbulcke M, Peeters R, Dupont P, Van Hecke P, Vandenberghe R. 2007. Word reading and posterior temporal dysfunction in amnestic mild cognitive impairment. Cereb Cortex. 17: 542-551.
87. Vandenbulcke M, Peeters R, Fannes K, Vandenberghe R. 2006. Knowledge of visual attributes in the right hemisphere. Nat Neurosci. 9: 964-970.
88. Vandenbulcke M, Peeters R, Van Hecke P, Vandenberghe R. 2005. Anterior temporal laterality in primary progressive aphasia shifts to the right. Ann Neurol. 58: 362-370.
89. Verhaeghen P, VandenbrouckeA, Dierckx V. 1998. Growing slower and less accurate: Adult age differences in time-accuracy functions for recall and recognition from episodic memory. Exp Aging Res. 24: 3-19.
90. Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, et al. 2011. Longitudinal assessment of A? and cognition in aging and Alzheimer disease. Ann Neurol. 69: 181-192.
91. Webster MJ, Herman MM, Kleinman JE, Shannon Weickert C. 2006. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns. 6: 941-951.
92. Whitney C, Kirk M, O'Sullivan J, Lambon Ralph MA, Jefferies E. 2011. The neural organization of semantic control: TMS evidence for a distributed network in left inferior frontal and posterior middle temporal gyrus. Cereb Cortex. 21: 1066-1075.
93. Whitney C, Kirk M, O'Sullivan J, Lambon Ralph MA, Jefferies E. 2012. Executive semantic processing is underpinned by a large-scale neural network: revealing the contribution of left prefrontal, posterior temporal, and parietal cortex to controlled retrieval and selection using TMS. J Cogn Neurosci. 24: 133-147.
94. Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, et al. 2009. Semantic memory activation in amnestic mild cognitive impairment. Brain. 132: 2068-2078.